CSIMarket
 

Anika Therapeutics Inc   (ANIK)
Other Ticker:  
 

Anika Therapeutics Inc 's Working Capital Per Sales

ANIK's Working Capital and Revenue growth



ANIK Working Capital Per Revenue (Dec 31 2023)
IV. Quarter
(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
Y / Y Working Capital Change -6.62 % -8.98 % -6.99 % -4.84 % 2.09 %
Y / Y Revenue Change 9.15 % 1.69 % 10.88 % 3.35 % 10.61 %
Working Capital Per Revenue 0.78 0.82 0.84 0.88 0.9
Total Ranking # 1660 # 1006 # 2511 # 2511 # 2507
Seq. Working Capital Change 2.75 % -0.02 % -2.2 % -7.06 % 0.16 %
Seq. Revenue Change 5.63 % -6.89 % 15.95 % -4.29 % -1.59 %





Comment on ANIK's Working Capital Per Revenue in the fourth quarter 2023
Anika Therapeutics Inc 's Working Capital Per Revenue in the Q4 2023 sequentially fell to 0.78 a new company low.

Within Healthcare sector 22 other companies have achieved lower Working Capital Per Revenue during the Q4 2023. While Working Capital Per Revenue total ranking has deteriorated in the fourth quarter 2023, compared to previous quarter from 1006 to 1660.
Working Capital Per Revenue Ranking
Within: No.
Industry # 5
Sector # 23
S&P 500 # 1660


Working Capital Per Revenue Statistics
High Average Low
1.78
1.32
0.78
(Dec 31 2018)   (Dec 31 2023)



Financial Statements
Anika Therapeutics Inc 's Working Capital $ 132 Millions Visit ANIK's Balance sheet
Anika Therapeutics Inc 's Revenues $ 43 Millions Visit ANIK's Income Statement
Where are ANIK's Sales coming from? Visit ANIK's Sales by Geography




Companies with similar Average Working Capital Per Revenue for 12 months ending Dec 31 2023, within Healthcare Sector Working Capital Per Revenue
Schrodinger Inc   2.14 
Pulmonx Corporation  2.08 
Aurinia Pharmaceuticals Inc   2.05 
Cue Health Inc   2.03 
Deciphera Pharmaceuticals Inc   2.02 
Guardant Health Inc   1.93 
Ocular Therapeutix Inc   1.92 
Procept Biorobotics Corporation  1.91 
Entrada Therapeutics Inc   1.90 
Arrowhead Pharmaceuticals Inc   1.89 
Cytek Biosciences Inc   1.87 
Utah Medical Products Inc  1.82 
Sophia Genetics Sa  1.82 
Novocure Limited  1.77 
Indivior Plc  1.74 
The Beauty Health Company  1.61 
Inmode Ltd   1.59 
Biomerica Inc   1.56 
Neuroone Medical Technologies Corporation  1.52 
Argenx se  1.48 
Inmed Pharmaceuticals Inc   1.45 
Clearpoint Neuro Inc   1.41 
Twist Bioscience Corporation  1.40 
Intra cellular Therapies Inc   1.28 
Urogen Pharma Ltd   1.27 
Si bone inc   1.24 
Orthopediatrics Corp  1.23 
Olink Holding Ab publ   1.23 
G1 Therapeutics Inc   1.23 
United Therapeutics Corporation  1.20 
Date modified: 2024-03-18T21:21:52+00:00



Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com